Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2001British Journal of CancerOpen Access

Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDoris MarkoUniversity of ViennaSSSilvia SchätzleUniversity of KaiserslauternAFAnna Maria FriedelCentre National de la Recherche Scientifique

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Marko et al. (2001) studied this question.

synapsesocial.com/papers/6a79f3ce9092edbae3f389f0https://doi.org/10.1054/bjoc.2000.1546
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cellular effects of olomoucine, an inhibitor of cyclin‐dependent kinases1995 · 140 citations
  2. 2New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening1990 · 9,831 citations
  3. 3Ran-independent nuclear import of cyclin B1–Cdc2 by importin β1999 · 85 citations
  4. 4CYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors1997 · 2,277 citations